Search - tctmd.com

Displaying 821 - 840 of 7547

Sort: Relevancy | Date

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

News Daily News

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Caitlin E. Cox

March 18, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Daily News

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

Caitlin E. Cox

March 12, 2024

News Opinion Off Script

This Women’s History Month, Let’s Make More Women’s Histories Possible

Annabelle Santos Volgman, MD

March 12, 2024

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

Advertisement

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Decades After WHI: Calcium, Vitamin D Linked to Different CVD, Cancer Outcomes

This Women’s History Month, Let’s Make More Women’s Histories Possible

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Patients With CKD Remain Underrepresented in Trials of CV Meds

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Semaglutide Winning Streak Continues in CKD With FLOW

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content